Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. LENZ Therapeutics Inc shares valued at $6,093,000 were sold by Versant Venture Capital VI, L. on Jun 27 ’25. At $30.46 per share, Versant Venture Capital VI, L. sold 200,000 shares. The insider’s holdings dropped to 1,767,275 shares worth approximately $60.55 million following the completion of this transaction.
Also, Versant Venture Capital VI, L. sold 133,924 shares, netting a total of over 4,051,201 in proceeds. Following the sale of shares at $30.25 each, the insider now holds 1,967,275 shares.
Before that, Versant Venture Capital VI, L. had sold 100,877 shares from its account. In a trade valued at $3,061,617, the 10% Owner traded LENZ Therapeutics Inc shares for $30.35 each. Upon closing the transaction, the insider’s holdings decreased to 100,877 shares, worth approximately $35.9 million.
Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of September 27, 2024, Raymond James has initiated its “an Outperform” rating for LENZ. Earlier on August 12, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for LENZ stock.
Analyzing LENZ Stock Performance
On last trading session,, LENZ Therapeutics Inc [NASDAQ: LENZ] plunged -1.61% to $34.26. The stock’s lowest price that day was $32.5215, but it reached a high of $35.4 in the same session. During the last five days, there has been a surge of approximately 10.66%. Over the course of the year, LENZ Therapeutics Inc shares have jumped approximately 86.40%. Shares of the company reached a 52-week high of $35.50 on 07/10/25 and a 52-week low of $16.53 on 04/09/25.
Support And Resistance Levels for LENZ Therapeutics Inc (LENZ)
According to the 24-hour chart, there is a support level at 32.69, which, if violated, would cause prices to drop to 31.12. In the upper region, resistance lies at 35.67. The next price resistance is at 37.07. RSI (Relative Strength Index) is 65.48 on the 14-day chart, showing neutral technical sentiment.
Is LENZ Therapeutics Inc subject to short interest?
Stocks of LENZ Therapeutics Inc saw a sharp rise in short interest on 2025-06-13 jumping by 23836.0 shares to 3.4 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.38 million shares. A jump of 0.7% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 15.08 of the overall float, the days-to-cover ratio (short ratio) jumped to 15.08.
Which companies own the most shares of LENZ Therapeutics Inc (LENZ)?
In terms of LENZ Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 51 in the next 12 months, up nearly 46.47% from the previous closing price of $34.82. Analysts anticipate LENZ Therapeutics Inc stock to reach 51 by 2025, with the lowest price target being 51. In spite of this, 2 analysts ranked LENZ Therapeutics Inc stock as Buy at the end of 2025.
